Lisinopril Dosing: Once Daily is Standard
Lisinopril should be dosed once daily, not twice daily, for hypertension and heart failure. The FDA-approved labeling and all major cardiovascular guidelines consistently recommend once-daily dosing for lisinopril 1.
FDA-Approved Dosing
The FDA label is explicit about lisinopril dosing 1:
- Hypertension: Initial dose 10 mg once daily, usual range 20-40 mg once daily, maximum studied dose 80 mg once daily
- Heart Failure: Initial dose 5 mg once daily (2.5 mg if hyponatremic), titrate to maximum 40 mg once daily
- Post-MI: 5-10 mg once daily for at least 6 weeks
The label makes no provision for twice-daily dosing and consistently specifies "once daily" administration across all indications.
Guideline Recommendations
Multiple major guidelines uniformly recommend once-daily lisinopril dosing 2, 3, 2, 4, 5, 6, 7:
- 2022 AHA/ACC/HFSA Heart Failure Guidelines: Target dose 20-40 mg once daily 6, 7
- 2005 European Heart Failure Guidelines: 5-20 mg daily (not divided) 2
- 2006 Canadian Heart Failure Guidelines: 20-35 mg once daily 3
The landmark ATLAS trial, which established lisinopril's efficacy in heart failure, used 32.5-35 mg daily as a single dose 2.
Research Evidence on Twice-Daily Dosing
While some small studies have explored twice-daily dosing, the evidence does not support changing clinical practice:
Against twice-daily dosing:
- A large retrospective study of 11,210 patients found no difference in blood pressure control between once-daily and twice-daily lisinopril (systolic BP difference -1.8 to 0.7 mmHg, diastolic -1.1 to 0.1 mmHg) 8
- Importantly, lisinopril 10 mg twice daily was associated with increased angioedema risk compared to 20 mg once daily (OR 2.27,95% CI 1.13-4.58) 8
Limited support for twice-daily:
- One small study (90 patients) showed greater BP reduction with twice-daily dosing (10.2/4.3 mmHg greater reduction), but this was a retrospective analysis with significant limitations 9
- A study in heart failure patients showed lower norepinephrine levels with twice-daily dosing, but no difference in clinical parameters, BNP, or cardiac function 10
Clinical Algorithm
If blood pressure is inadequately controlled on lisinopril:
- First: Increase to maximum once-daily dose (40 mg for most indications, up to 80 mg studied in hypertension) 1
- Second: Add a complementary agent (thiazide diuretic, calcium channel blocker) rather than splitting the dose 11, 1
- Third: Consider switching to an alternative RAAS inhibitor if truly refractory
Do not split to twice-daily dosing because:
- No FDA approval for this regimen
- No guideline support
- Reduced medication adherence with twice-daily regimens
- Potential increased adverse event risk
- No proven clinical benefit in large studies
Important Caveats
- Renal impairment: Dose adjustment needed if CrCl <30 mL/min, but still dosed once daily 1
- Pediatric patients: May require weight-based dosing but still once daily 1
- Combination therapy: When adding diuretics, may need to reduce lisinopril dose temporarily, but maintain once-daily schedule 1
The pharmacokinetic half-life of lisinopril (approximately 12 hours) supports once-daily dosing, and the extensive clinical trial data demonstrating mortality and morbidity benefits were all based on once-daily administration 2, 3, 2, 4, 6, 7.